AwesomeCapital
Search This Blog
Wednesday, May 29, 2019
Puma Biotechnology (PBYI) PT Lowered to $24 at Goldman Sachs
Analyst Paul Choi lowered the price target on Puma Biotechnology (NASDAQ:
PBYI
) to $24.00 (from $29.00) while maintaining a Neutral rating.
https://www.streetinsider.com/Analyst+PT+Change/Puma+Biotechnology+%28PBYI%29+PT+Lowered+to+%2424+at+Goldman+Sachs/15550459.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.